A Study Of Functional Polymers For Diagnosing Airway Complications Of Gastroesophageal Reflux Disease

Overview

About this study

The purpose of this study is to determine that BioNylon can be specifically degraded by gastric secretions and not by normal respiratory secretions, we aim to collect gastric and tracheobronchial secretions from patients undergoing evaluation for GERD and LPR to test BioNylon degradation in a bench model.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • Adult patients (>18 years) undergoing routine upper endoscopy and/or bronchoscopy for diagnosis of GERD with respiratory symptoms suspected of LPR.

 

Exclusion Criteria:

  • Patients on proton pump inhibitor (PPI), H2 blockers, antacid medication.

  • Patients with prior gastric or esophageal surgery.

  • Patients with known vagal nerve injury.

  • Minorities as previously described.

  • Adults lacking capacity to consent.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 9/25/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Brian Lacy

Open for enrollment

Contact information:

Melissa Wren

(904) 953-2454

Wren.Melissa@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20597331

Mayo Clinic Footer